Metronomia today announced the signing of a Master Services Agreement with one of the major global biotech companies. After an international selection process Metronomia has been awarded as the preferred provider for all non-interventional and observational studies in Germany, Austria and Switzerland.

“We are very pleased about being selected preferred provider by one of the largest global bniotech companies,” said Rudolf Köhne-Volland, Metronomia Managing Director. “We very much acknowlege the trustfullness and credit given by and see this as an obligation to deliver best services in all aspects.”